Anavex Life Sciences Corp.
AVXL
$2.78
-$0.07-2.50%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/9/2026
-
Globe Newswire
9/8/2026
-
Globe Newswire
9/6/2026
-
MarketBeat
9/2/2026
-
Globe Newswire
9/1/2026
-
Globe Newswire
8/27/2026
-
The Cerbat Gem
8/27/2026
-
Tickeron - Stocks
8/26/2026
-
Insider Monkey
8/26/2026
-
MarketBeat
8/25/2026
-
The Cerbat Gem
8/25/2026
-
GuruFocus
8/25/2026
-
Seeking Alpha - Healthcare
8/25/2026
-
Globe Newswire
8/21/2026
-
Tickeron - Stocks
8/21/2026
-
Tickeron - Stocks
8/17/2026
-
Globe Newswire
8/14/2026
-
Tickeron - Stocks
8/12/2026
-
MarketBeat
8/11/2026
-
TipRanks
8/11/2026
-
MarketBeat
8/3/2026
-
MarketBeat
8/3/2026
-
Seeking Alpha - Healthcare
8/3/2026
-
Globe Newswire
8/1/2026
-
The Cerbat Gem
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, August 28, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Feb 8 and 12 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
844 689 3939
Address
630 5th Avenue
20th Floor
New York, NY 10111
20th Floor
New York, NY 10111
Country
Year Founded
Business Description
Sector
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental...
more